Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID 2 min read People and Community Tevogen Bio to Study Therapeutic Potential of its Investigational COVID-19 T Cell Therapy in Long COVID AETOSWire November 24, 2022 WARREN, N.J.: Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in...Read More
